Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Criteria for determining the dosage and drug resistance of tablets

From: Virulence characteristics and antibiotic resistance analysis of Klebsiella pneumoniae isolated from pig farms in Xinjiang, China: revealing potential zoonotic risks

Antibiotic name

Drug content (µg/tablet)

Criteria for determining the diameter of the antibacterial zone/ mm

R

I

S

PEN

10 U

≤ 13

14–16

≥ 17

AMX

10

≤ 13

14–16

≥ 17

CFB

30

≤ 19

20–22

≥ 23

K

30

≤ 13

14–17

≥ 18

GM

10

≤ 12

13–15

≥ 16

ENR

5

≤ 13

14–16

≥ 17

CIP

5

≤ 21

22–25

≥ 26

DX

30

≤ 10

11–13

≥ 14

TMP

23.75/1.25

≤ 10

11–15

≥ 16

FON

30

≤ 12

13–16

≥ 17

PB

30 IU

≤ 8

9–11

≥ 12

CTX

30

≤ 22

23–25

≥ 26

AMP

10

≤ 13

14–16

≥ 17

IPM

10

≤ 19

20–22

≥ 23

TCY

30

≤ 11

12–14

≥ 15

CRO

30

≤ 19

20–22

≥ 23

CA

30

≤ 14

15–16

≥ 17